Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Annals of Hematology
Published in: Annals of Hematology 8/2003

01-08-2003 | Letter to the Editor

Challenges with linezolid therapy and reversible pancytopenia

Authors: H. S. Nimeiri, D. S. Nemiary

Published in: Annals of Hematology | Issue 8/2003

Login to get access

Excerpt

Linezolid is currently holding an important place in the antimicrobial armamentarium; however, not enough attention has focused on its hematotoxicity and its pathogenesis .We report here a case of reversible pancytopenia that appeared after 1 month of linezolid therapy. …
Literature
1.
Moellering RC (2003) Linezolid: the first oxazolidinone antimicrobial. Ann Intern Med 138:135–142CrossRefPubMed
2.
3.
Attassi K, Hershberger E, Alam R, Zervos MJ (2002) . Clin Infect Dis 35:347–348
4.
Yunis AA (1989) Chloramphenicol toxicity: 25 years of research. Am J Med 87 [Suppl 3N]:44N–48N
5.
Jimenez JJ, Arimura GK, Abou-Khalil WH, Isildar M, Yunis AA (1987) Chloramphenicol-induced bone marrow injury: possible role of bacterial metabolites of chloramphenicol. Blood 70:1180–1185PubMed
Metadata
Title
Challenges with linezolid therapy and reversible pancytopenia
Authors
H. S. Nimeiri
D. S. Nemiary
Publication date
01-08-2003
Publisher
Springer Berlin Heidelberg
Published in
Annals of Hematology / Issue 8/2003
Print ISSN: 0939-5555
Electronic ISSN: 1432-0584
DOI
https://doi.org/10.1007/s00277-003-0681-6

Other articles of this Issue 8/2003

Annals of Hematology 8/2003 Go to the issue

Original Article

High-dose hydroxyurea in the treatment of poor-risk myeloid leukemias

Original Article

Involvement of Fas and TNF pathways in the induction of apoptosis of T cells by antithymocyte globulin

Case Report

Testicular plasmacytoma with bone dissemination without medullary plasmacytosis

Case Report

Plasmablastic lymphoma presenting in a human immunodeficiency virus-negative patient: a case report

Original Article

Telomere length shortening in non-Hodgkin's lymphoma patients undergoing chemotherapy

Original Article

CXCR4 and SDF-1 expression in B-cell chronic lymphocytic leukemia and stage of the disease
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits